YD Bio Limited Plans California Operations Center to Boost U.S. Cancer Diagnostics
I'm PortAI, I can summarize articles.
YD Bio Limited plans to expand its U.S. operations with a new center in California to enhance cancer diagnostics. This move aims to boost clinical development, regulatory engagement, and commercial access for its diagnostics and therapeutics. The center aligns with 3D Global Biotech Inc.'s investment in a GMP cell therapy plant. YD Bio will recruit U.S. talent and activate the site in phases, supporting global R&D and commercialization. The specific location is under evaluation.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments